HUMAN XTENSIONS LTD. Financials Human Xtensions Ltd.
Equities
HUMX
IL0011700007
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.3 ILa | +2.78% |
|
+1.61% | -65.82% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 683.7 | 127.1 | 18.89 | 34.68 |
| Enterprise Value (EV) 1 | 542.9 | 29.35 | -38.08 | 11.31 |
| P/E ratio | -8.66 x | -2.36 x | -0.42 x | -0.95 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 3,30,49,534 x | 4,55,42,823 x | 59,53,284 x | 70,05,220 x |
| EV / Revenue | 2,62,44,931 x | 1,05,19,167 x | -1,20,02,594 x | 22,84,412 x |
| EV / EBITDA | -20.4 x | -0.55 x | 0.86 x | -0.3 x |
| EV / FCF | -3,73,76,154 x | -12,97,859 x | 14,86,685 x | -5,65,930 x |
| FCF Yield | -0% | -0% | 0% | -0% |
| Price to Book | 4.59 x | 1.22 x | 0.31 x | 1.33 x |
| Nbr of stocks (in thousands) | 26,664 | 26,756 | 26,756 | 26,756 |
| Reference price 2 | 25.64 | 4.749 | 0.7060 | 1.296 |
| Announcement Date | 18/03/21 | 24/03/22 | 23/03/23 | 28/03/24 |
1ILS in Million2ILS
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | 12.19 | 20.69 | 2.79 | 3.173 | 4.95 |
| EBITDA 1 | -30.43 | -47.92 | -26.58 | -52.99 | -44.04 | -37.26 |
| EBIT 1 | -30.83 | -48.54 | -27.21 | -53.65 | -44.65 | -37.78 |
| Operating Margin | - | -398.29% | -131.53% | -1,923.05% | -1,407.09% | -763.17% |
| Earnings before Tax (EBT) 1 | -28.58 | -49.15 | -28.54 | -53.62 | -44.59 | -36.64 |
| Net income 1 | -28.58 | -49.15 | -28.54 | -53.62 | -44.59 | -36.64 |
| Net margin | - | -403.36% | -137.98% | -1,921.97% | -1,405.36% | -740.1% |
| EPS 2 | -18.10 | -31.13 | -2.959 | -2.010 | -1.670 | -1.369 |
| Free Cash Flow | - | -15.86 | -14.53 | -22.61 | -25.62 | -19.98 |
| FCF margin | - | -130.15% | -70.22% | -810.5% | -807.34% | -403.66% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 16/11/20 | 16/11/20 | 18/03/21 | 24/03/22 | 23/03/23 | 28/03/24 |
1ILS in Million2ILS
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 11.3 | 19.1 | 141 | 97.7 | 57 | 23.4 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | -15.9 | -14.5 | -22.6 | -25.6 | -20 |
| ROE (net income / shareholders' equity) | - | -274% | -33.7% | -42.3% | -53.6% | -83.4% |
| ROA (Net income/ Total Assets) | - | -94.4% | -16.2% | -23.4% | -28.9% | -44% |
| Assets 1 | - | 52.09 | 176.4 | 229.4 | 154.1 | 83.29 |
| Book Value Per Share 2 | 9.810 | 12.90 | 5.580 | 3.910 | 2.310 | 0.9800 |
| Cash Flow per Share 2 | 7.130 | 14.70 | 5.520 | 2.200 | 1.110 | 0.4700 |
| Capex 1 | 0.58 | 1.39 | 0.25 | 0.44 | 0.44 | 0.19 |
| Capex / Sales | - | 11.37% | 1.18% | 15.81% | 13.87% | 3.84% |
| Announcement Date | 16/11/20 | 16/11/20 | 18/03/21 | 24/03/22 | 23/03/23 | 28/03/24 |
1ILS in Million2ILS
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -65.82% | 3.18M | |
| +73.43% | 12.41B | |
| -18.48% | 8.23B | |
| +0.83% | 6.46B | |
| +15.76% | 5.5B | |
| -4.95% | 5.33B | |
| +40.80% | 5.1B | |
| -18.32% | 4.05B | |
| -29.60% | 2.54B | |
| +7.56% | 1.99B |
- Stock Market
- Equities
- HUMX Stock
- Financials Human Xtensions Ltd.
